Balasch-Bernat, Mercè http://orcid.org/0000-0002-0216-0628
Sentandreu-Mañó, Trinidad http://orcid.org/0000-0003-4405-0539
Tomás, José M. http://orcid.org/0000-0002-3424-1668
Cebrià i Iranzo, Maria A. http://orcid.org/0000-0001-8803-3963
Tortosa-Chuliá, Maria A. http://orcid.org/0000-0001-8576-8454
Arnal-Gómez, Anna http://orcid.org/0000-0003-1025-2239
Cezón-Serrano, Natalia http://orcid.org/0000-0002-9084-2089
Clinical trials referenced in this document:
Documents that mention this clinical trial
Deepening the understanding of the structural validity of the Tilburg Frailty Indicator
https://doi.org/10.1007/s40520-023-02407-w
Funding for this research was provided by:
Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana (GV/2019/131)
Spanish National Plan for Scientific and Technical Research and Innovation (PID2021-124418OB-I00)
Universitat de Valencia
Article History
Received: 1 March 2023
Accepted: 2 April 2023
First Online: 21 April 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: Approval was obtained from the Ethics Committee for Human Research of the University of Valencia (No. H1542733812827). The procedures performed in this study were in accordance with the ethical standards of the institutional research ethics committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.